Orungan, Macy Kim S.

HRN: 23-05-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2023
CEFTRIAXONE 1G (VIAL)
09/20/2023
09/27/2023
IV
440mg
Q24
PCAP-C
Waiting Final Action 
09/24/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/24/2023
10/01/2023
IVT
70mg IVT
OD
PCAP-C
Waiting Final Action 
09/26/2023
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
09/26/2023
09/30/2023
ORAL
0.5
OD
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: